Concepedia

Barbara M. Davit

BM

21

Publications

1.3K

Citations

18

H-Index

1999

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Pfizer (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

The University of Texas at Austin

Barbara M. Davit is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyBioanalysisDrug DevelopmentPharmacokineticsChromatographyPharmacokinetic ModelingBiostatistics

Publications per year

1999–2017

21

Publications

21

Dissolution Testing for Generic Drugs: An FDA Perspective

Om Anand, Lawrence X. Yu, Dale P. Conner et al. · The AAPS Journal · 2011 · 260 citations · Full text

Drug Analysis, Bioequivalence, Drug Purity +4

Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development

Xinyuan Zhang, Robert Lionberger, Barbara M. Davit et al. · The AAPS Journal · 2011 · 127 citations · Full text

Physiologically Based Pharmacokinetics, Drug Design, Drug Discovery +12

Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications

Barbara M. Davit, Dale P. Conner, Beth Fabian-Fritsch et al. · The AAPS Journal · 2008 · 127 citations · Full text

Bioequivalence, Pharmacology, Bioequivalence Data Submitted +6

In vitro–In Vivo Correlations: Tricks and Traps

J Cardot, Barbara M. Davit · The AAPS Journal · 2012 · 117 citations · Full text

Signal Transduction, In Vivo System, Cell Culture +4

Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs

Sam Haidar, Fairouz Makhlouf, Donald J. Schuirmann et al. · The AAPS Journal · 2008 · 101 citations · Full text

Pharmacokinetic Modeling, Bioequivalence, Medicine +9

Rows per page

1–5 of 21